CASI Pharmaceuticals, Inc. (CASI) — SEC filings
Recent SEC filings for CASI Pharmaceuticals, Inc. — 10-K, 10-Q, 8-K, proxy statements, and insider transactions.
| Form Type | Filing Date | Accepted Date |
|---|---|---|
| 25-NSE | 2026-06-23 | 2026-06-23 |
| 6-K | 2026-06-02 | 2026-06-02 |
| SC 13D/A | 2026-05-18 | 2026-05-18 |
| 20-F | 2026-05-15 | 2026-05-15 |
| D | 2026-04-28 | 2026-04-28 |
| 3 | 2026-04-23 | 2026-04-23 |
| NT 20-F | 2026-04-21 | 2026-04-21 |
| 3 | 2026-04-20 | 2026-04-20 |
| 6-K | 2026-04-20 | 2026-04-20 |
| 6-K | 2026-04-20 | 2026-04-20 |
| 3 | 2026-04-16 | 2026-04-16 |
| 6-K | 2026-04-15 | 2026-04-15 |
| 3 | 2026-04-13 | 2026-04-13 |
| 3 | 2026-04-07 | 2026-04-07 |
| 3 | 2026-04-03 | 2026-04-03 |
| 3 | 2026-04-03 | 2026-04-03 |
| 3 | 2026-03-27 | 2026-03-27 |
| 3 | 2026-03-25 | 2026-03-25 |
| SC 13D/A | 2026-03-23 | 2026-03-23 |
| 3 | 2026-03-18 | 2026-03-18 |
Recent SEC filings.